Mucormycosis infection in maxillary sinus: a case report
Article Sidebar
Main Article Content
Abstract
Mucormycosis is a deep fungal infection caused by Mucorales order disseminated via soil and air which can occur in both human and animal. Most of human infected cases take sporan giospore from inhalation or direct contact to their injured mucosa or skin. Mucormycosis has been usually found in immunocompromised patients such as hematologic malignancies, bone marrow
transplantation and poor-controlled diabetic patients and often involves the craniofacial regions.
Thai female, 62 years old, with underlying diseases; diabetes mellitus type 2, asthma and chronic kidney disease stage 2 had alveolar bone exposed at left side of maxilla after tooth extraction. Surgical debridement and primary closure were done but the condition was not improved so she was referred to Oral and Maxillofacial Surgery Clinic, to continue the treatment. The incisional biopsy was performed with the result of mucormycosis infection. The destruction of left maxillary sinus along with anterior part of left ethmoidal air cells was found from computed tomography.
The treatments of this case were discussed in role of surgery, antifungal therapy with the side effect during the treatment and the defect reconstruction thereafter
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The opinions and content expressed in the articles are solely those of the individual authors and do not necessarily reflect the views of the journal or the authors’ affiliated institutions. Authors are fully responsible for the accuracy and correctness of their work.
Any reuse, reproduction, or redistribution of the articles, content, data, or images in other forms requires prior written permission from the Thai Journal of Oral and Maxillofacial Surgery
References
Centers for Disease Control and Prevention. Mucormycosis: the basics. [cited 2017 Apr 16]. Available from: http://https://
www.cdc.gov/fungal/diseases/mucormycosis/index.html
Neville BW, Damm DD, Allen CM, Chi AC. Mucormycosis. In: Oral and maxillofacial pathology. 4th ed. Canada: Elsvier; 2016. p. 215-7.
Mantadakis E, Samonis G. Clinical presentation of zygomycosis. Clin Microbiol Infect. 2009;15 Suppl 5:15-20.
Lanternier F, Lortholary O. Zygomycosis and diabetes mellitus. Clin Microbiol Infect. 2009;15 Suppl 5:21-5.
Boonsuk J. Mucormycosis. Thai J Tubercul Chest Dis Crit Care. 2013;34:160-81.
Powers AC. Diabetes mellitus: complications in Harrisons priciples of internal medicine. In: Harrison TR, editor. 19th ed. McGraw-Hill; 2015. p. 2422-30.
Metzen D, Böhm H, Zimmermann M, Reuther T, Kübler AC, Müller-Richter UD. Mucormycosis of the head and neck. J Craniomaxillofac Surg. 2012;40:e321-7.
Vijayabala GS, Annigeri RG, Sudarshan R. Mucormycosis in a diabetic ketoacidosis patient. Asian Pac J Trop Biomed. 2013;3:830-3.
American Diabetes Association. Glycemic targets: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S66-76.
Papadogeogakis N, Parara E, Petsinis V, Vourlakou C. A case of successfully treated rhinocerebral mucormycosis: dental implications. Int J Dent. 2010;2010:1-4.
Luna B, Drew RH, Perfect JR. Overview of antifungal agents. Otolaryngol Clin North Am. 2000;30:203-15.
Department of Pharmaceutical Sciences, Rajavithi Hospital. Amphotericin B in high risk drug practice guidelines. Rajavithi Hospital. Protexts.com: Bangkok; 2560. p. 13-7.
Shaw JR, Brown JS. Reconstruction of the new maxilla and midface: introducing a new classification. Lancet Oncol. 2010;11:1001-8